IMMUNIC, INC. 8-K Filing

From the Filing

EDGAR Filing Documents for 0001193805-26-000382 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193805-26-000382 Filing Date 2026-04-01 Accepted 2026-04-01 07:00:32 Documents 13 Period of Report 2026-03-27 Items Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 e665306_8k-immunic.htm iXBRL 8-K 21600 2 e665306_ex99-1.htm EX-99.1 9976 6 GRAPHIC image_001.jpg GRAPHIC 3195 Complete submission text file 0001193805-26-000382.txt 205716 Data Files Seq Description Document Type Size 3 XBRL SCHEMA FILE imux-20260327.xsd EX-101.SCH 3002 4 XBRL LABEL FILE imux-20260327_lab.xml EX-101.LAB 34239 5 XBRL PRESENTATION FILE imux-20260327_pre.xml EX-101.PRE 22350 16 EXTRACTED XBRL INSTANCE DOCUMENT e665306_8k-immunic_htm.xml XML 3311 Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818 IMMUNIC, INC. (Filer) CIK : 0001280776 (see all company filings) EIN. : 562358443 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 26824649 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)